HIV-1 treatment timing shapes the human intestinal memory B-cell repertoire to commensal bacteria
- PMID: 37816704
- PMCID: PMC10564866
- DOI: 10.1038/s41467-023-42027-6
HIV-1 treatment timing shapes the human intestinal memory B-cell repertoire to commensal bacteria
Abstract
HIV-1 infection causes severe alterations of gut mucosa, microbiota and immune system, which can be curbed by early antiretroviral therapy. Here, we investigate how treatment timing affects intestinal memory B-cell and plasmablast repertoires of HIV-1-infected humans. We show that only class-switched memory B cells markedly differ between subjects treated during the acute and chronic phases of infection. Intestinal memory B-cell monoclonal antibodies show more prevalent polyreactive and commensal bacteria-reactive clones in late- compared to early-treated individuals. Mirroring this, serum IgA polyreactivity and commensal-reactivity are strongly increased in late-treated individuals and correlate with intestinal permeability and systemic inflammatory markers. Polyreactive blood IgA memory B cells, many of which egressed from the gut, are also substantially enriched in late-treated individuals. Our data establish gut and systemic B-cell polyreactivity to commensal bacteria as hallmarks of chronic HIV-1 infection and suggest that initiating treatment early may limit intestinal B-cell abnormalities compromising HIV-1 humoral response.
© 2023. Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests.
Figures






References
-
- Li, H. et al. Mucosal or systemic microbiota exposures shape the B cell repertoire. Nature584, 274–278 (2020). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous